Patients’ clinical characteristics |
|
ALL(n=12) |
AML(n=15) |
APL(n=1) |
Sex: Male/Female |
|
7:5 |
2:1 |
0:1 |
Age: |
|
7(3.3-14.8) |
11(0.6-15.4) |
8 |
Chromosomal karyotype |
|
|
|
|
|
Normal karyotype |
10(83.3%) |
13(86.6%) |
1(100%) |
|
Hyperdiploid |
2(16.7%) |
0 |
0 |
|
-7 |
0 |
1(6.7%) |
0 |
|
t(7; 11)(p15; p15) |
0 |
1(6.7%) |
0 |
Level of risk |
|
|
|
|
|
Low risk |
1(8.3%) |
3(20.0%) |
1(100%) |
|
Intermediate risk |
9(75.0%) |
2(13.3%) |
0 |
|
High risk |
2(16.7%) |
10(66.7%) |
0 |
Treatment protocols |
|
|
|
|
|
Targeted drugs |
3(25.0%) |
7(46.7%) |
0 |
|
Transplantation |
0 |
9(60.0%) |
0 |